TY - JOUR T1 - Adjusting to Disrupted Assessments, Placements and Teaching (ADAPT): a snapshot of the early response by UK medical schools to COVID-19 JF - medRxiv DO - 10.1101/2020.07.29.20163907 SP - 2020.07.29.20163907 AU - Anmol Arora AU - Georgios Solomou AU - Soham Bandyopadhyay AU - Julia Simons AU - Alex Osborne AU - Ioannis Georgiou AU - Catherine Dominic AU - Shumail Mahmood AU - Shreya Badhrinarayanan AU - Syed Rayyan Ahmed AU - Jack Wellington AU - Omar Kouli AU - Robin Jacob Borchert AU - Joshua Feyi-Waboso AU - Scott Dickson AU - Savraj Kalsi AU - Dimitrios Karponis AU - Timothy Boardman AU - Harmani Kaur Daler AU - Abbey Boyle AU - Jessica Speller AU - Conor S Gillespie AU - Jie Man Low AU - Ratnaraj Vaidya AU - Ngan Hong Ta AU - Steven Aldridge AU - Jonathan Coll Martin AU - Natasha Douglas AU - Mary Goble AU - Tayyib Abdel-Hafiz Goolamallee AU - Emma Jane Norton AU - Andre Chu AU - Inshal Imtiaz AU - Oliver P Devine Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/08/01/2020.07.29.20163907.abstract N2 - Background Medical school assessments, clinical placements and teaching have been disrupted by the COVID-19 pandemic. The ADAPT consortium was formed to document and analyse the effects of the pandemic on medical education in the United Kingdom (UK), with the aim of capturing current and future snapshots of disruption to inform trends in the future performance of cohorts graduating during COVID-19.Methods Members of the consortium were recruited from various national medical student groups to ensure representation from medical schools across the UK. The groups involved were: Faculty of Medical Leadership and Management Medical Students Group (FMLM MSG); Neurology and Neurosurgery Interest Group (NANSIG); Doctors Association UK (DAUK); Royal Society of Medicine (RSM) Student Members Group and Medical Student Investigators Collaborative (MSICo.org). In total, 29 medical schools are represented by the consortium. Our members reported teaching postponement, examination status, alternative teaching provision, elective status and UK Foundation Programme Office (UKFPO) educational performance measure (EPM) ranking criteria relevant to their medical school during a data collection window (1st April 14:00 to 2nd April 23:59).Results All 29 medical schools began postponement of teaching between the 11th and 17th of March 2020. Changes to assessments were highly variable. Final year examinations had largely been completed before the onset of COVID-19. Of 226 exam sittings between Year 1 and Year 4 across 29 schools: 93 (41%) were cancelled completely; 14 (6%) had elements cancelled; 57 (25%) moved their exam sitting online. 23 exam sittings (10%) were postponed to a future date. 36% of cohorts with cancelled exams and 74% of cohorts with online exams were granted automatic progression to the next academic year. There exist 19 cohorts at 9 medical schools where all examinations (written and practical) were initially cancelled and automatic progression was granted.Conclusions The approaches taken by medical schools have differed substantially, though there has been universal disruption to teaching and assessments. The data presented in this study represent initial responses, which are likely to evolve over time. In particular, the status of future elective cancellations and UK Foundation Programme Office (UKFPO) educational performance measure (EPM) decile calculations remains unclear. The long-term implications of the heterogeneous disruption to medical education remains an area of active research. Differences in specialty recruitment and performance on future postgraduate examinations may be affected and will be a focus of future phases of the ADAPT Study.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study received no external funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:None of the data presented in this manuscript are personal data. The work presented was exempted from ethical review by the University College London (UCL) Research Ethics Committee (30/03/20).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe authors declare that the key aggregated data supporting the findings of this study are available within the article (Figure 2). Other raw data are available from the corresponding author, OPD, upon reasonable request. ER -